Opioid ligands are a class of G protein-coupled receptors known as opioid receptors. Dynorphins, enkephalins, endorphins, endomorphins, and nociceptin are examples of endogenous opioids. There are many opioid receptors in the brain, as well as in the spinal cord and digestive system. The body has molecules or sites called opioid receptors that are triggered by opioid substances. Opioid receptors prevent impulses from traveling along excitatory pathways in the human body.The serotonin, catecholamine, and substance P pathways are some of these pathways, and they are all thought to play a role in pain perception and feelings of wellbeing. Mu, delta, and kappa receptors are additional subclassifications of opioid receptors. While each class has its own unique way of acting, they all have some fundamental things in common. The potassium pump mechanism, which is present on the plasma membrane of most cells, powers them all.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V77133 | CTAP TFA | CTAP TFA is a specific, BBB (blood-brain barrier) permeable (penetrable) μ opioid receptor antagonist (inhibitor) with IC50 of 3.5 nM. | |
|
V77132 | CTOP TFA | CTOP TFA is a specific μ-opioid receptor antagonist. | |
|
V2282 | CYM51010 | 1069498-96-9 | CYM51010 (also known as ML335; CYM-51010; CID23723457), is a biased ligand of μ-opioid receptor – δ-opioid receptor heterodimers (EC50=403 nM), exhibiting anti-nociceptive activity similar to morphine but with a decreased levels of tolerance development and withdrawal symptoms. |
|
V69895 | Cyprodime | 118111-54-9 | Cyprodime is a selective μ opioid receptor (MOR) antagonist (inhibitor) with Ki of 5.4, 244.6, and 2187 nM for μ, δ, and κ, respectively. |
|
V69901 | Cyprodime hydrochloride | 2387505-50-0 | Cyprodime HCl is a selective μ-opioid receptor antagonist (inhibitor) with Kis of 5.4 nM, 244.6 nM and 2187 nM for μ, δ and κ opioid receptors respectively. |
|
V69935 | D-Ala-Gly-Phe-Met-NH2 | 82948-89-8 | D-Ala-Gly-Phe-Met-NH2 is an opioid peptide and a potent opioid delta receptor agonist (activator). |
|
V69964 | D-Ala-Gly-Phe-Met-NH2 monoacetate | 100929-65-5 | D-Ala-Gly-Phe-Met-NH2 monoacetate is an opioid peptide and a potent opioid delta receptor agonist (activator). |
|
V79355 | D3R/MOR antagonist 1 | D3R/MOR antagonist 1 (Compound 114) is a D3R/MOR antagonist (Ki 46.5 nM and 691 nM, respectively). | |
|
V78834 | D3R/MOR antagonist 2 | D3R/MOR antagonist 2 (Compound 121) is a D3R/MOR antagonist (Ki 46.5 nM and 691 nM, respectively). | |
|
V69957 | Dalargin | 81733-79-1 | Dalargin is a potent δ-opioid receptor agonist. |
|
V77107 | DALDA acetate | DALDA acetate is a potent and selective μ-opioid receptor agonist/activator with a Ki of 1.69 nM. | |
|
V79008 | DALDA TFA | DALDA TFA is a potent and selective μ-opioid receptor agonist/activator with a Ki of 1.69 nM. | |
|
V29335 | DAMGO | 78123-71-4 | DAMGO is a selective μ-opioid receptor (μ-OPR) agonist with Kd of 3.46 nM. |
|
V28668 | DAMGO TFA | 950492-85-0 | DAMGO TFA is a selective μ-opioid receptor (μ-OPR) agonist with Kd of 3.46 nM. |
![Deltorphin 2 TFA ([D-Ala2]-Deltorphin II TFA)](http://www.invivochem.com/upload/1124/V77093.png)
|
V77093 | Deltorphin 2 TFA ([D-Ala2]-Deltorphin II TFA) | Deltorphin 2 TFA is a selective delta opioid receptor peptide agonist. | |
|
V69978 | Dermorphin Analog | 115814-08-9 | Dermorphin Analog is an analogue of Dermorphin. |
|
V19863 | Difelikefalin | 1024828-77-0 | Difelikefalin (MR-13A9; CR-845; MR-13A-9; trade name Korsuva) is a novel, peripherally specific, and potent kappa opioid receptor agonist approved in 2021 asan analgesic opiod peptide for the treatment of moderate-to-severe itching. |
|
V69918 | DIPPA hydrochloride | 155512-52-0 | DIPPA ( HCl) is an irreversible, long-acting, selective and high-affinity kappa-opioid receptor antagonist. |
|
V69882 | DPDPE | 88373-73-3 | DPDPE is an opioid peptide and a selective opioid receptor (DOR) agonist with anticonvulsant (antiepileptic/antiseizure) properties. |
|
V69885 | DPDPE TFA | 172888-59-4 | DPDPE TFA is an opioid peptide and a selective opioid receptor (DOR) agonist with anticonvulsant (antiepileptic/antiseizure) properties. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
